Marksans Pharma

BSE : NSE :
Sector :

Pharmaceuticals & Drugs

Compare

Comment

Ratings

Standalone Consolidated

Market Cap(₹Cr.)

52 Weeks High/Low

Last Closing Price

Stock P/E

Book Value

Dividend Yield

P/B

Pledged

Face Value

Enterprise Value

EV/EBIDTA

Gross NPA

Net NPA

Capital Adequecy Ratio

Price Chart (Only Standalone)

PE Price

1w
1m
3m
6m
1Yr
3Yr
5Yr
10Yr

Quarterly Results ( Figures in Rs. Crores.)

Profit & Loss ( Figures in Rs. Crores.)

Balance Sheet ( Figures in Rs. Crores.)

Cash Flows ( Figures in Rs. Crores.)

Historical Growths

Compounded Sales Growth

Compounded Profit Growth

Compounded Expense Growth

Stock Price CAGR

Ratios ()

Major Shareholders

Shareholders more than 1%

Corporate Action

Documents

Presentation & Earning Calls	Annual Reports	Credit Rating
No document is available	No document is available	No document is available

TATA Tax Saving Fund-ELSS

Marksans Pharma

Highlights

Highlights

Price Chart (Only Standalone)

Quarterly Results ( Figures in Rs. Crores.)

Profit & Loss ( Figures in Rs. Crores.)

Balance Sheet ( Figures in Rs. Crores.)

Cash Flows ( Figures in Rs. Crores.)

Historical Growths

Ratios ()

Major Shareholders

Shareholders more than 1%

Corporate Action

Documents

Overview

LATEST UPDATE

REPORTS

LATEST NEWS

Comment

Yadnya Academy Pvt Ltd

PRODUCTS

COMPANY

LEGAL

TATA Tax Saving Fund-ELSS

Marksans Pharma

Marksans Pharma

CompanyOver

Highlights

Highlights

Price Chart (Only Standalone)

Quarterly Results ( Figures in Rs. Crores.)

Profit & Loss ( Figures in Rs. Crores.)

Balance Sheet ( Figures in Rs. Crores.)

Cash Flows ( Figures in Rs. Crores.)

Historical Growths

Ratios ()

Major Shareholders

Shareholders more than 1%

Corporate Action

Documents

Overview

LATEST UPDATE

REPORTS

LATEST NEWS

Comment